The frequency and clinical significance of <i>centromere enumeration probe 17</i> alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer-Reference-Cited by-同舟云学术

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

Published:2022-08-08 Issue:4 Volume:81 Page:511-519
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Katayama Ayaka¹²^ORCID,Starczynski Jane³,Toss Michael S¹,Shaaban Abeer M³⁴,Provenzano Elena⁵^ORCID,Quinn Cecily M⁶,Callagy Grace⁷,Purdie Colin A⁸,Millican‐Slater Rebecca⁹,Purnell David¹⁰,Chagla Leena¹¹,Oyama Tetsunari²,Pinder Sarah E¹²^ORCID,Chan Steve¹³,Ellis Ian¹¹⁴,Lee Andrew H S¹⁴^ORCID,Rakha Emad A¹¹⁴^ORCID

Affiliation:

1. Translational Medical Sciences Unit School of Medicine, University of Nottingham Nottingham UK

2. Diagnostic Pathology Gunma University Graduate School of Medicine Maebashi Japan

3. Department of Cellular Pathology University Hospitals Birmingham NHS Foundation Trust Edgebaston Birmingham UK

4. Institute of Cancer and Genomic Sciences, The University of Birmingham Edgebaston Birmingham UK

5. Department of Histopathology Cambridge University NHS Foundation Trust Cambridge UK

6. Department of Histopathology St. Vincent's University Hospital, Dublin, and School of Medicine, University College Dublin Dublin Ireland

7. Discipline of Pathology School of Medicine, Lambe Institute for Translational Research, NUI Galway Ireland

8. Department of Breast Pathology Ninewells Hospital and Medical School Dundee UK

9. Department of Histopathology St James's University Hospital Leeds UK

10. Histopathology Department University Hospitals of Leicester Leicester UK

11. Burney Breast Unit St Helens and Knowsley Teaching Hospital NHS Trust Prescot UK

12. Division of Cancer Studies King's College London, Guy's Hospital London UK

13. Department of Oncology Nottingham University Hospitals NHS Trust Nottingham UK

14. Department of Histopathology Nottingham University Hospitals NHS Trust Nottingham City Hospital Nottingham UK

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14728

Reference30 articles.

1. Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

2. Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

3. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

5. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma;HISTOL HISTOPATHOL;2024